EU GMP Draft Annex 1: Potential impact on cleaning and disinfection

Register & watch

Thursday, September 19, 2019
11:00 to 12:00 CEST (Berlin, Paris, Madrid)

Cleaning and microbial contamination control are critical focus areas in pharmaceutical and medical device industries.

Robust cleaning and disinfection programmes are needed to meet the required cleanroom microbial grades, to prevent cross contamination and subsequent microbial contamination of products. EU Annex 1, which specifies guidance for the manufacture of sterile medicinal products was first issued in 1989 and has not been updated since 2007. With no complete review of the annex having been carried out for over 10 years, a complete review and rewrite was needed.

With over 30 years of experience in developing and manufacturing cleanroom contamination control products, let Contec help lead you through the proposed changes for biodecontamination control in EU GMP Annex 1. This webinar explores all the general changes in the annex, with specific reference to contamination control strategy. The references to cleaning and disinfection have been expanded, and the webinar will discuss this in more detail.

Although the annex is still at a draft stage, and there has been a call for a further consultation phase, there is a widely held view that the general direction of travel shown in the document will not change. It would be prudent to plan ahead with any disinfectant validation with these core principles in mind, as it likely that many will appear in the finished document.

Register & watch

Presented by:

Karen Rossington

Karen Rossington is a Marketing Consultant, specialising in the life science contamination control industry. With a BSc in Business Studies and Engineering, Karen has spent 25 years in the industry in both sales/marketing, R&D and regulatory roles. Working initially for an isolator manufacturer, and more recently with leading contamination control consumable suppliers, Karen has a broad depth of experience in the life science contamination control sector. Karen has presented at many international conferences on the subject of disinfectant testing and contamination control, and contributes as a lecturer on the PTQA Masters course.

Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. One of our greatest strengths comes from having a global infrastructure that is strategically located to support the needs of our customers. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world.